ALIVE HealthTech Growth Fund

A growth-stage HealthTech fund investing in Israeli and international mid-to-late stage medical device and digital health companies.

Venture Capital Savyon, Israel Est. 2020
Visit website ↗ LinkedIn
Last updated 2026-09-22
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
1
Rounds' value
$24.0M
total disclosed, rounds participated
Stages
Growth, Pre-IPO, Series A, Series B, Series C

About

ALIVE is an Israeli health-focused venture capital firm that partners with major healthcare institutions to back technology companies shaping the future of global health. The firm invests in advanced-stage HealthTech and digital health startups with strong clinical evidence, commercial traction, and clear pathways to global markets. ALIVE leverages an exclusive ecosystem of strategic partnerships with hospital chains, HMOs, and financial institutions to support and accelerate portfolio companies' clinical and commercial expansion.

Portfolio · 1

UltraSight
UltraSight develops AI-driven software for real-time guidance in cardiac ultrasound imaging.
Led ★ 1 round $24.0M committed Latest: 2026-09

Q&A

What is ALIVE HealthTech Growth Fund's primary investment focus?
ALIVE HealthTech Growth Fund focuses on growth-stage HealthTech, digital health, and medical device companies with strong clinical evidence and commercial traction, particularly those with clear pathways to global markets.
When was ALIVE HealthTech Growth Fund founded?
ALIVE HealthTech Growth Fund was founded in 2020.
What is the total AUM for ALIVE HealthTech Growth Fund?
ALIVE HealthTech Growth Fund has a total AUM of $200 million.
What is the typical check size for ALIVE HealthTech Growth Fund?
ALIVE HealthTech Growth Fund typically invests between $2 million and $40 million per company.
Which investment stages does ALIVE HealthTech Growth Fund target?
ALIVE HealthTech Growth Fund targets Growth, Pre-IPO, Series A, Series B, and Series C investment stages.
What are the preferred sectors for ALIVE HealthTech Growth Fund investments?
ALIVE HealthTech Growth Fund prefers to invest in Health Tech & Life Sciences, Digital Health, Medical Devices, Biomed, Artificial Intelligence, and Biotechnology sectors.
What is the status of ALIVE HealthTech Growth Fund's funds?
ALIVE HealthTech Growth Fund has raised ALIVE One in 2020 with $110 million, and is planning ALIVE Growth Fund III in 2025 with a target size of $200 million.
Who are the co-founders and managing general partners of ALIVE HealthTech Growth Fund?
The co-founders and managing general partners of ALIVE HealthTech Growth Fund include Prof. Rafi Beyar, Prof. Ari Shamiss, and Michel Habib. Dudi Klein is also a Co-Founder and Managing Partner.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)